A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma
- 31 January 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 54 (3), 440-447
- https://doi.org/10.1016/j.jaad.2005.11.1063
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Different low doses of broad‐band UVA in the treatment of morphea and systemic sclerosisPhotodermatology, Photoimmunology & Photomedicine, 2004
- Evaluation of Medium-Dose UVA1 Phototherapy in Localized Scleroderma with the Cutometer and Fast Fourier Transform MethodDermatology, 2003
- Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cellsJournal of the American Academy of Dermatology, 2001
- Combined Treatment with Calcipotriol Ointment and Low‐Dose Ultraviolet A1 Phototherapy in Childhood MorpheaPediatric Dermatology, 2001
- Low‐dose broad‐band UVA in morphea using a new method for evaluationPhotodermatology, Photoimmunology & Photomedicine, 2000
- Low-dose UVA1 phototherapy for treatment of localized sclerodermaJournal of the American Academy of Dermatology, 1998
- High-dose UVA1 radiation therapy for localized sclerodermaJournal of the American Academy of Dermatology, 1997
- PUVA Bath Photochemotherapy for Localized SclerodermaArchives of Dermatology, 1996
- Classification of Morphea (Localized Scleroderma)Mayo Clinic Proceedings, 1995
- Treatment of localised scleroderma with PUVA bath photochemotherapyThe Lancet, 1994